rectosigmoid 7.3 junction cancer, ki-ras- 231/ Ki-ras+ vs g/day 1.13 (0.70-1.90) ≥30 ≤0 Incidence, colon 148/ cancer, men, vs g/day 1.24 (0.70-2.30) ≥30 ≤0 Women, ki-ras+ vs g/day 1.83 (0.80-4.10) ≥30 ≤0 140/ Women, ki-ras- vs g/day 0.65 (0.10-5.50) ≥30 ≤0 Incidence, rectal 63/ cancer, men, vs g/day 2.00 (0.80-5.30) ≥30 ≤0 1.25 27/ Women, ki-ras+ vs g/day ≥30 ≤0 0.1-29.9 vs ≤0 24/ Women, ki-ras- 0.98 (0.40-2.20) g/day Incidence, 82 cancer, men, 1.15 (0.50-2.60)
7.3 rectosigmoid junction cancer, ki-ras- 231/ Ki-ras+ ≥30 vs ≤0 g/day 1.13 (0.70-1.90) 148/ Incidence, colon cancer, men, ≥30 vs ≤0 g/day 1.24 (0.70-2.30) 140/ Women, ki-ras+ ≥30 vs ≤0 g/day 1.83 (0.80-4.10) Women, ki-ras- ≥30 vs ≤0 g/day 0.65 (0.10-5.50) 63/ Incidence, rectal cancer, men, ≥30 vs ≤0 g/day 2.00 (0.80-5.30) 27/ Women, ki-ras+ ≥30 vs ≤0 g/day 1.25 24/ Women, ki-ras- 0.1-29.9 vs ≤0 g/day 0.98 (0.40-2.20) 82 Incidence, cancer, men, 1.15 (0.50-2.60)
CUP_colorectal_SLR_2016_RO.docx